Nguyen, G., Morris, S., Kwange, S. O., Chen, A., Hamilton, A., Steuerwald, N., Moore, D., Hanson, S., Musselwhite, L. W., Kadakia, K. C., Hwang, J. J., Patel, J. N. (2025). Dosing tolerability and adverse events (AEs) in dihydropyrimidine dehydrogenase (
            <i>DPYD</i>
            ) variant carriers receiving genotyping-guided fluoropyrimidine (FP) dosing.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3095